Priser
Platform
Blog
Om os
Download
002030
Daan Gene Co
Shenzhen Stock Exchange (Hong Kong)
0

Om

Daan Gene Co., Ltd. is a prominent biotechnology company that specializes in the research, development, and commercialization of diagnostic products and services. With a strong focus on molecular diagnostics, the company provides various genomic testing solutions essential for detecting infectious diseases, genetic disorders, and cancer. Operating in a sector that significantly influences healthcare, pharmaceuticals, and life sciences, Daan Gene plays a critical role in promoting advanced diagnostic techniques that assist in early disease detection and management. By leveraging cutting-edge technology and fulfilling the diagnostic needs of hospitals, research institutions, and laboratories, Daan Gene Co., Ltd. contributes to improving healthcare systems' efficiency and effectiveness worldwide. Its innovative approach and commitment to high-quality product development ensure its significant presence in the global biotechnology market, particularly in regions looking to enhance their medical diagnostic capabilities.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I DAAN GENE CO MED ENDAVU: Køb Daan Gene Co ($002030) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Daan Gene Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker002030
Land
Kina
Antal medarbejdere1.730
Hjemmesidedaangene.com
SektorSundhed
IndustriBioteknologi

Udbytter

0,02CNH
'19
0,02CNH
'20
0,34CNH
'21
1,11CNH
'22
1,75CNH
'23
0,02CNH
'24
Ex-udbytte-dato14. jun. 2024
Udbytteafkast0,26%